title: Unpurged ABMT for neuroblastoma: AIEOP-BMT experience.
authors.affiliation: Istituto Giannina Gaslini (IGG), Genova, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Dini
authors.forename: E
authors.initials: E
authors.lastname: Lanino
authors.forename: A
authors.initials: A
authors.lastname: Garaventa
authors.forename: P
authors.initials: P
authors.lastname: Paolucci
authors.forename: A
authors.initials: A
authors.lastname: Amici
authors.forename: F
authors.initials: F
authors.lastname: Locatelli
authors.forename: P
authors.initials: P
authors.lastname: Colleselli
authors.forename: L
authors.initials: L
authors.lastname: Boni
authors.forename: S
authors.initials: S
authors.lastname: Dallorso
authors.forename: O
authors.initials: O
authors.lastname: Abla
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007223:Infant; D007558:Italy / Q000453:epidemiology; D008297:Male; D009447:Neuroblastoma / Q000188:drug therapy / Q000401:mortality / Q000601:surgery*; D011379:Prognosis; D012074:Remission Induction; D014182:Transplantation, Autologous